
Gelteq Limited Ordinary Shares
GELSHealthcare|Drug Manufacturers - Specialty & Generic|AU
$0.44
-0.02 (-3.42%)
Cash / Share
$0.00
About
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Stock Price
-58.9%(1Y)
1M
-19.8%
3M
-21.1%
6M
-6.4%
YTD
-45.0%
1Y
-56.9%
3Y
-85.0%
5Y
-85.0%
Pipeline Summary
0 total trials0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Key Facts
Market Cap$4.0M
Employees7
CEONathan Jacob Givoni
IPO DateOct 29, 2024
Beta-0.36
52-Week Range$0.387 – $2.01
Avg Volume2,769,907
ExchangeNASDAQ
Websitegelteq.com
Ownership
Float39.6%
Shares Outstanding9.2M
Recent Insider Trades
WYNNE Paul MichaelOTHER
Mar 18, 20260 shares
Szewach Simon HOTHER
Mar 18, 20260 shares
Szewach Simon HOTHER
Jul 1, 202665,000 shares @ $2.00
Karp Bradley GlennOTHER
Mar 18, 20260 shares
Givoni Nathan JOTHER
Mar 18, 20260 shares
Peers
Recent News
Gelteq Limited (NASDAQ:GELS) Stock Short Interest Report for September
Oct 13, 2026 · defenseworld.net
Data last updated: Nov 9, 2026, 04:11 AM